ArticleACS omega2024
Design and Optimization of High-Performance Novel RbPbBr
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- An integrated DFT + U and device simulation design of doped CsGeClScientific reports · 2026Article
- Multiscale quantum-to-device simulation framework for CaScientific reports · 2026Article
- First-principles investigation and device simulation of TlPbIRSC advances · 2026Article
- Numerical modeling to enhance the efficiency of experimentally fabricated SbRSC advances · 2026Article
- Revolutionizing environment friendly FASnIScientific reports · 2025Article
- Scrutinizing the untapped potential of emerging ABSeScientific reports · 2025Article
- A comprehensive study on electron and hole transport layers for designing and optimizing the efficiency of MoSeHeliyon · 2024Article
- Numerical analysis and device modelling of a lead-free SrRSC advances · 2024Article
- Solar power conversion: CuI hole transport layer and BaRSC advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inorganic cubic rubidium-lead-halide perovskites have attracted considerable attention owing to their structural, electronic, and unique optical properties. In this study, novel rubidium-lead-bromide (RbPbBr
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.